A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer

Clinical Trial ID NCT02019693

PubWeight™ 3.18^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02019693

Top papers